Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women

American Journal of Clinical Nutrition

Volumn 71, Issue 6, 2000, Pages 1462-1469

  Merz Demlow, Barbara E ^b   Duncan, Alison M ^b   Wangen, Kerry E ^b   Xu, Xia ^b   Carr, Timothy P ^b   Phipps, William R ^b   Kurzer, Mindy S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

Apoli poprotein A I; Apolipoprotein B; Cholesterol; HDL; Isoflavone; LDL; Lipids; Lipoprotein(a); Menstrual cycle; Phytoestrogen; Soy; Triacylglycerol; Women

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; ISOFLAVONE DERIVATIVE; LIPID; LOW DENSITY LIPOPROTEIN; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; CROSSOVER PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MENSTRUAL CYCLE; NORMAL HUMAN; PREMENOPAUSE; PROTEIN DIET; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0034042698     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.6.1462     Document Type: Article

References (56)

1. American Heart Association. 1998 Heart and stroke statistical update. Dallas: American Heart Association, 1997.
2. Balmir F, Staack R, Jeffrey E, et al. An extract of soy flour influences serum cholesterol and thyroid hormones in rats and hamsters. J Nutr 1996;126:3046-53.
3. Anthony MS, Clarkson TB, Bullock BC, Wagner JD. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 1997;17:2524-31.
4. Tovar-Palacio C, Potter SM, Hafermann JC, Shay NF. Intake of soy protein and soy protein extracts influences lipid metabolism and hepatic gene expression in gerbils. J Nutr 1998;128:839-42
5. Sirtori CR, Zucchi-Dentone C, Sirtori M, et al. Cholesterol-lowering and HDL-raising properties of lecithinated soy proteins in type II hyperlipidemic patients. Ann Nutr Metab 1985;29:348-57.
6. Carroll KK. Review of clinical studies on cholesterol-lowering response to soy protein. J Am Diet Assoc 1991;91:820-7.
7. Cassidy A, Bingham S, Setchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-40.
8. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82.
9. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(suppl): 1375S-9S.
10. Potter SM. Soy protein and serum lipids. Curr Opin Lipidol 1996; 7:260-4.
11. Wong WW, Smith EO, Stuff JE, Hachey DL, Heird WC, Pownell HJ. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr 1998; 68(suppl):1385S-9S.
12. Giovannetti PM, Carroll KK, Wolfe BM. Constancy of fasting serum cholesterol of healthy young women upon substitution of soy protein isolate for meat and dairy protein in medium and low fat diets. Nutr Res 1986;6:609-18.
13. Cassidy A, Bingham S, Setchell K. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br Med J 1995;74:587-601.
14. Anthony MS, Clarkson TB, Hughes CL, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996;126:43-50.
15. Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 1998;128: 954-9.
16. Anthony MS, Clarkson TB, Hughes CL. Plant and mammalian estrogen effects on plasma lipids of female monkeys. Circulation 1994;90:I-235 (abstr).
17. Honore EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 1997;67:148-54.
18. Crouse JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 1999;159:2070-6.
19. Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and per-imenopausal women. ArteriosclerThromb Vasc Biol 1997;17:3392-8.
20. Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Croft KD. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr 1998;128:728-32.
21. Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 1999;84:192-7.
22. Wang HJ, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994;42:1666-73.
23. Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged 16 to 72 years. Br J Nutr 1974;32:77-97.
24. Carr TP, Andresen CJ, Rudel LL. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 1993;26:39-42.
25. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-505.
26. Rifai N, King ME. Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum. Clin Chem 1986;32:957-61.
27. Smith SJ, Cooper GR, Henderson LO, et al. An international collaborative study on standardization of apolipoproteins A-I and B. Clin Chem 1987;33:2240-9.
28. Tijssen P. Practice and theory of enzyme immunoassays. In: Burdon RH. van Knippenberg PH, ed. Laboratory techniques in biochemistry and molecular biology. Vol 15. Amsterdam: Elsevier Science Publishers BV, 1985:345-7.
29. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982;23:97-104.
30. SAS Institute, Inc. Statistical Analysis System, version 6.12. Cary, NC: SAS Institute, Inc. 1993.
31. Kim HJ, Kalkhoff RK. Changes in lipoprotein composition during the menstrual cycle. Metabolism 1979;28:663-8.
32. Woods M, Schaefer EJ, Morrill A, et al. Effect of menstrual cycle phase on plasma lipids. J Clin Endocrinol Metab 1987;65:321-3.
33. Lussier-Cacan S, Xhignesse M, Desmarais JL, Davignon J, Kafrissen ME, Chapdelaine A. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy. Metabolism 1991;40:849-54.
34. Schijf CP, van der Mooren MF, Doesburg WH, Thomas CM, Rolland R. Differences in serum lipids, lipoproteins, sex hormone binding globulin and testosterone between the follicular and the luteal phase of the menstrual cycle. Acta Endocrinol (Copenh) 1993;129:130-3.
35. Lyons Wall PM, Choudhury N, Gerbrandy EA, Truswell AS. Increase of high-density lipoprotein cholesterol at ovulation in healthy women. Atherosclerosis 1994;105:171-8.
36. Tonolo G, Ciccarese M, Brizzi P, et al. Cyclical variation of plasma lipids, apolipoproteins, and lipoprotein(a) during the menstrual cycle of normal women. Am J Physiol 1995;269:E1101-5.
37. Muesing RA, Forman MR, Graubard BI, et al. Cyclic changes in lipoprotein and apolipoprotein levels during the menstrual cycle in healthy premenopausal women on a controlled diet. J Clin Endocrinol Metab 1996;81:3599-603.
38. Tikkanen MJ. Sex hormones. In: Betteridge DJ, Illingworth DR, Shepherd J, eds. Lipoproteins in health and disease. New York: Oxford University Press, Inc, 1999:967-84.
39. Low-Beer TS. Nutrition and cholesterol gallstones. Proc Nutr Soc 1985;44:127-34.
40. Cullinane EM, Yurgalevitch SM, Saritelli AL, Herbert PN, Thompson PD. Variations in plasma volume affect total and low-density lipoprotein cholesterol concentration during the menstrual cycle. Metabolism 1995;44:965-71.
41. Carr BR, MacDonald PC, Simpson ER. The role of lipoproteins in the regulation of progesterone secretion by the human corpus luteum. Fertil Steril 1982;38:303-11.
42. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet. IV. Particular saturated fatty acids in the diet. Metabolism 1965;14:776-86.
43. Boyd NF, Cousins M, Beaton M, Kriukov V, Lockwood G, Tritchler D. Quantitative changes in dietary fat intake and serum cholesterol in women: results from a randomized, controlled trial. Am J Clin Nutr 1990;52:470-6.
44. Rader DJ, Hoeg JM, Brewer HB. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med 1994;120:1012-25.
45. Orth-Gomer K, Mittleman MA, Schenck-Gustafsson K, et al. Lipoprotein (a) as a determinant of coronary heart disease in young women. Circulation 1997;95:329-34.
46. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-81.
47. Baum JA, Teng H, Erdman JW, et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholes-terolemic, postmenopausal women. Am J Clin Nutr 1998;68:545-51.
48. Gooderham MH, Adlercreutz H, Ojala ST, Wahala K, Holub BJ. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr 1996;126:2000-6.
49. Axelson M, Sjovall J, Gustafsson BE, Setchell KDR. Soya - a dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol 1984;102:49-56.
50. Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S. Bioavailability of soybean isoflavones depends on gut microflora in women. J Nutr 1995;125:2307-15.
51. US Department of Health and Human Services. The Surgeon General's report on nutrition and health. Washington, DC: US Government Printing Office, 1988. [DHHS (PHS) publication 88 50210.]
52. Katan MB, Beynen AC. Characteristics of human hypo- and hyper-responders to dietary cholesterol. AmJ Epidemiol 1987;125:387-99.
53. Coward L, Barnes NC, Setchell KDR, Barnes S, Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 1993;41:1961-7.
54. Nagata C, Takatsuka N, Kurisu Y, Shimizu H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 1998;128:209-13.
55. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89: 1329-45.
56. Anthony MS, Clarkson TB, Williams JK. Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am J Clin Nutr 1998; 68(suppl):1390S-3S.